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a b s t r a c t
Structural traits of permeation enhancers are important determinants of their capacity to promote
enhanced drug absorption. Therefore, in order to obtain a better understanding of structure–activity
relationships for permeation enhancers, a Quantitative Structural Activity Relationship (QSAR) model
has been developed.
The random forest-QSAR model was based upon Caco-2 data for 41 surfactant-like permeation
enhancers from Whitehead et al. (2008) and molecular descriptors calculated from their structure.
The QSAR model was validated by two test-sets: (i) an eleven compound experimental set with Caco-2
data and (ii) nine compounds with Caco-2 data from literature. Feature contributions, a recent developed
diagnostic tool, was applied to elucidate the contribution of individual molecular descriptors to the pre-
dicted potency. Feature contributions provided easy interpretable suggestions of important structural
properties for potent permeation enhancers such as segregation of hydrophilic and lipophilic domains.
Focusing on surfactant-like properties, it is possible to model the potency of the complex pharmaceutical
excipients, permeation enhancers. For the ﬁrst time, a QSAR model has been developed for permeation
enhancement. The model is a valuable in silico approach for both screening of new permeation enhancers
and physicochemical optimisation of surfactant enhancer systems.
 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Development of oral delivery systems for proteins and peptides
offers the promise of improved patient compliance compared to
conventional parenteral administration. However, bioavailability
is, in part, limited due to poor absorption of proteins across the
intestinal epithelial barrier. To effectively deliver a protein
systemically this barrier can be modulated by the presence of
permeation enhancers [1].
Quantitative Structural Activity Relationship, QSAR methods
have been applied extensively for exploration of structural
properties of importance for oral absorption of new chemical
entities, e.g., QSAR models have been developed for permeability
[2] and solubility [3–5]. To our knowledge, no QSAR model for
permeation enhancement has previously been published.
Some permeation enhancers have speciﬁc mechanisms of
action, e.g., modulating the function of tight junctions in the
plasma membrane such as zona-occludens-toxin [6], EDTA [7] or
melittin [8]. However, the majority of permeation enhancers are
primarily surfactants and will non-speciﬁcally disrupt the lipid
bilayer packing of phospholipids in the epithelial membrane [1].
Surfactants are molecules having segregated lipophilic and
hydrophilic domains. Water soluble surfactants tend to pool in
the surfaces of water/air and water/lipid, lowering the surface ten-
sion. Lowering of surface tensions of water/air surfaces and the
ability to enhance the permeability across lipid bilayers correlated
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well for a selection of surfactant-like permeation enhancers [9].
General relations between molecular structures and physicochem-
ical properties of surfactants are thoroughly described by Rosen
[10]. Several properties of surfactants, including surface pressure,
have previously been modelled with a QSAR approach applying
both linear regression and non-linear machine learning models
as artiﬁcial neural networks, support vector machine or random
forest [5,11,12]. Combining the above mentioned concepts, it
seems plausible that a QSAR-model of surfactant-like permeation
enhancement could be constructed.
Our modelling is based on a Caco-2 data set for 41 surfactant
permeation enhancers from Whitehead [13,14] tested in cell
monolayers across three concentrations. Hereby, trade-offs
between potency, pathway and safety amongst a selection of
mainly surfactant-like permeation enhancers were investigated.
For this article only the potency data was used. In vitro Caco-2
monolayers are cultures of functional, differentiated enterocytes
and are widely employed to evaluate permeability rates of drug
candidates or pre-formulations [15]. The Caco-2 data for perme-
ation enhancers from Whitehead [13,14] together with molecular
descriptors calculated from structure of these surfactants were
the basis for the QSAR model.
Non-linear machine learning models can have superior predic-
tive capabilities compared to classical statistical explanatory mod-
elling. However, such machine learning models are often complex
‘‘black boxes’’ – difﬁcult to interpret and discuss [16]. This article
presents a promising method to elucidate the interplay of features
comprising good permeation enhancers within the complex
non-linear model of random forest. Therefore, based on the devel-
oped model, we here can recommend ranges of the selected molec-
ular descriptors to obtain high permeation enhancement potency.
2. Materials and methods
2.1. Materials
Caco-2 cells (ATTC-HTB-37) were obtained from American Type
Culture Collection (Manassas, VA). Cell culture media (Dulbecco’s
modiﬁed essential media (DMEM)) and penicillin/streptomycin
were purchased from Lonza (Verviers, Belgium). All other supple-
ments (i.e., foetal bovine serum, HEPES buffer and non-essential
amino acids (NEAA)) as well as Hanks’ balanced salt solution
(HBSS) and trypsin were purchased from Gibco, Life Technologies
(Carlsbad, CA). Corning Transwell ﬁlter inserts (1.12 cm2 surface
area, 0.4 lm pore diameter) were purchased from Fisher
Scientiﬁc (Waltham, MA). Bovine serum albumin (BSA) was pur-
chased from Sigma Aldrich (St. Louis, MO). All other reagents were
of the highest analytical grade.
2.2. Cell culture and TEER measurements
Caco-2 cells (passage numbers 41–49) were seeded at a density
of 2.5  105 cells/ﬂask and grown to 70–90% conﬂuence in DMEM
(supplemented with 10% FBS, 100 U/ml penicillin and 100 lg/ml
streptomycin and 1% (v/v) NEAA). For transport studies, Caco-2
monolayers were cultured on permeable Transwell 12 mm diam-
eter inserts at a density of 105 cells/cm2 and used after 14–17 days
in culture. Cells were cultured at 37 C and 5% CO2 atmosphere and
the medium was changed every other day. Monolayers were equi-
librated in HBSS-based transport buffer 1 h prior to testing.
Transepithelial electrical resistance (TEER) was measured with a
chop-stick electrode (Millicell-ERS, Millipore, Billerica, MA) prior
to testing, and monolayers with TEER values <600X cm2 were dis-
carded. TEER was measured after 1 h exposure to permeation
enhancers.
3. Data processing
3.1. Training set
Whitehead et al., tested the ability of 51 permeation enhancers
to lower the barrier integrity marker %TEER in Caco-2 cells at 1%,
0.1% and 0.01% (w/v) and published the data set as supplementary
materials in two papers [13,14]. Of the 51 permeation enhancers
reported, forty-two had computable molecular structures
(non-mixtures) and were a wide selection of enhancers which
were ascribed to 10 different categories of surfactants: Anionic sur-
factants, cationic surfactants, zwitterionic surfactants, non-ionic
surfactants, bile salts, fatty acids, fatty esters, fatty amines, sodium
salts of fatty acids, nitrogen-containing rings and others [13]. EDTA
(a calcium chelator) was excluded from the training set because of
a non-surfactant-like mechanism together with high potency. The
remaining 41 permeation enhancers had surfactant-like structures
or low potency e.g., urea could be described as an ineffective
surfactant without permeation enhancement effect.
TEER-potency (Tpot) was deﬁned to concatenate measurements
of TEER%-decrease (EP) at the three different concentrations
(0.01%, 0.1% and 1% w/v) into one target variable. Tpot was simply
deﬁned as the mean TEER%-decrease across the three concentra-
tions as given in Eq. (1). Tpot = 1 corresponds to a permeation
enhancer lowering TEER% completely at 0.01% (w/v) and Tpot = 0
translates to no effect of a permeation enhancer on TEER% even
at 1% (w/v). The TEER%-decrease EP is deﬁned as in Eq. (2) and
depends of the TEER% before and after treatment with enhancer
plus TEER%+ the background ﬁlter resistance.
Tpot ¼ EP½0:01% þ EP½0:1% þ EP½1%3 ð1Þ
EP ¼ 1 TEER%AE  TEER%þ
TEER%noAE  TEER%þ ð2Þ
From a statistical point of view the loss of information is mini-
mal, as the TEER%-values of the three concentrations were highly
correlated. The loadings of the ﬁrst principal component of a prin-
cipal component analysis resembled the deﬁnition of Tpot and this
principal component explained 71% of the variance. From a practi-
cal viewpoint Tpot could be seen as a linear approximation of pEC50
(log effective concentration (w/v) of where 50% TEER-decrease is
observed), see Eq. (3). pEC50 itself is dimensionless.
Thus, for a given permeation enhancer having a potency of
pEC50 = 1 the corresponding value of Tpot = 0.5.
Tpot ¼ pEC50þ 0:53 ; for pEC50 2 ½0:5;2:5 ð3Þ
3.2. Software packages, descriptors and model design
The open source R statistical software (v 3.02) was acquired
freely from http://www.r-project.org and Rstudio integrated devel-
opment environment (v 0.98.501) also acquired freely from http://
www.rstudio.com. The R-package ‘randomForest’ (v.4.6) [17,18]
was used in the random forest-QSAR model. CAS identiﬁcation
numbers of compounds in the training set were converted to
mol-ﬁles through SciFinder [19]. Mol-ﬁles bundled in sdf-ﬁles
were imported to the software application MOE [20] and sequen-
tially pre-processed with the following functions: ‘wash’ (simulat-
ing an ideal solubilised molecular form), ‘partial charges MMFFA96x’
calculating the electron densities necessary for a number of
descriptor algorithms, and ﬁnally ‘energy minimize’ relaxing the
molecule in the minimum state. All 2D molecular descriptors pro-
vided by MOE were computed. The subgroup of 3D descriptors
‘vsurf’ [21] plus the single 3D descriptor ‘dipole’ were calculated
as they were relatively fast to compute and therefore suitable for
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screening purposes. One new descriptor carbon chain length (CCL)
was implemented through R. CCL is the length of the longest satu-
rated non-substituted aliphatic carbon chain of a given permeation
enhancer. Table 1 explains the simple implementation of CCL. After
266 molecular descriptors were acquired, a variable ﬁltering was
performed to increase prediction performance. First, ﬁfteen
descriptors were excluded for having the same value for more than
95% of the actual training-set. A descriptor having the same value
for all permeation enhancers does not provide any information and
is problematic for some algorithms which e.g., divide by the vari-
ance, which will be zero. Subsequently, 143 redundant descriptors
were ﬁltered off, one at a time, until no remaining descriptor
pair-wise correlations exceeded rp = 0.9 (Pearson correlation).
This correlation-ﬁltering was a simpliﬁed implementation of the
CORCHOP routine [22]. Lastly, the remaining descriptors were ﬁl-
tered by their Spearman rank correlation coefﬁcient (rs) to the tar-
get variable, Tpot. As Spearman rank correlation utilises the target
parameter (Tpot), it was computed separately on training data for
each fold of the cross-validations, so as to avoid latently overﬁtting.
Nevertheless, the random forest algorithm was a robust model and
the root mean square error estimated by leave one out
cross-validation (RMSELOO-CV) exhibited a variation of less than
20% for any reasonable subsets of pruning parameters. The 30 best
rs-correlating (or inverse-correlating) descriptors were included in
the model. See Table 2 gives an overview of the descriptors
selected for the model. Fig. 1 depicts the data ﬂow from molecular
formulas, computation of molecular descriptors, variable ﬁltering,
model training and cross-validation.
The default parameters of the random forest model were used
as provided in the R-CRAN package ‘randomForest’, though the
number of decision trees grown was set to 10,000 or 50,000 to
ensure a conveniently high reproducibility between model-runs.
Variable importance was computed for any descriptor and
described the deterioration in prediction accuracy of the model,
when permuting the particular descriptor. Variable importance
was used to rank the importance of the descriptors and did not
inﬂuence the model predictions. However, variable importance
was a valuable tool to identify the molecular descriptors/features
most important for predicting surfactant-like permeation
enhancement.
To assess the mechanics of the random forest-QSAR, the pack-
age rfFC [23,24], which is a diagnostic extension for random forest,
was acquired from https://r-forge.r-project.org/projects/rffc/. rfFC
provides forest contributions which is the mean contribution of a
given variable to the Tpot prediction of a given permeation
enhancer.
3.3. Experimental test set
A set of 11 compounds and an additional 3 compounds from the
training set were tested in Caco-2 monolayers to generate an
experimental test set for validation of the developed random
forest-QSAR model. Contrary to the experimental setup of the
training data, the experimental test conducted for this paper differs
in terms of media (HBSS versus DMEM, respectively) and incuba-
tion times (60 min versus 15 min, respectively). Likewise, mor-
phology of Caco-2 monolayers is expected to have some inter-lab
variation [25]. The most lipophilic permeation enhancers were
barely soluble at 1% (w/v) at 37 C and needed to be maintained
at this temperature during the experiment at all times to avoid
precipitation. Model predictions were compared to experimentally
measured values of Tpot. The Squared Pearson correlation coefﬁ-
cient (rp2) and the root mean square error of ordinary least square
ﬁt (RMSEOLS) were used as the validation criteria for the linear rela-
tionship between model predictions and experimental values. It is
acceptable that the slope and offset deviates from 1 and 0
respectively as the absolute measured Tpot is method speciﬁc.
3.4. Literature test set
Based on a literature search, nine permeation enhancers were
included as a literature test set (Table 3). For all included
Table 1
Examples of the new descriptor carbon chain length (CCL). CCL estimates the longest sequence of saturated carbon atoms by counting the longest sequence of capital C’s in a
corresponding SMILES representation of the structure.
Name Structure Smiles underscoring CCL count
Decanoate O@C(O)CCCCCCCCC 9
3-Hydroxydecanoic acid CCCCCCCC(CC(@O)O)O 8
Benzoic acid O@C(O)c1ccccc1 1
Table 2
Overview of the 30 descriptors applied in the random forest-QSAR model predicting
the potency of surfactant-like permeation enhancers in Caco-2 monolayers.
Descriptors were computed through MOE (18) except CCL ‘‘carbon chain length’’
implemented for this article.
Group of descriptors: Amount used Names of descriptors
as available in MOE
Atom counts and bond counts 3 a_nN
a_nS
b_double
Kier–Hall & Kappa shape: 1 chi1_C
Adjacency and distance matrix: 8 BCUT_SLOGP_0,
BCUT_SLOGP_3
BCUT_SMR_3
GCUT_PEOE_0
GCUT_PEOE_3
GCUT_SMR_0
wienerPath
Pharmacophore feature: 1 a_base
Partial charge: 10 Q_PC+
PEOE_RPC+
PEOE_PC+
Q_VSA_PPOS
Q_VSA_POL
Q_VSA_FPNEG
PEOE_VSA_POL
PEOE_VSA_FPPOS
PEOE_VSA+5
PEOE_VSA+1
PEOE_VSA-1
Surface area, volume and shape: 4 vsurf_IW3
vsurf_ID8
vsurf_CP
vsurf_Wp 2
Conformation dependent charge: 1 dipole
Physical properties: 1 logP(o/w)
New descriptor in this article: 1 CCL ‘‘carbon chain length’’
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permeation enhancers from the literature, pEC50 was estimated by
interpolation to compare across various experimentally applied
concentrations. pEC50 is the negative logarithm of EC50 and has
an approximate linear relation to Tpot, as described in (Eq. (3)).
The model performance was validated by the accuracy of the
pEC50 prediction for the permeation enhancer in the literature test
set. Again the main criteria for comparison were rp2 and RMSEOLS
between interpolated pEC50 values and predicted Tpot values.
4. Results
A random forest-QSAR model was developed based on a 41
compound training set from literature [13,14] and permeation
enhancement potency (TEER% Caco-2) values were matched with
molecular descriptors. The predictability of the model was tested
through validation. Three types of validation were applied:
Internal leave-one-out cross validation, (LOO-CV), experimental
validation and literature validation. Lastly, the mechanics from
the autonomous random forest-QSAR model was extracted to pro-
vide a complimentary insight into which molecular properties
there are important for permeation enhancement potency.
4.1. Model validation
Internal cross-validation was used throughout the process of
designing a predictive generalisable model of permeation enhance-
ment. Table 4 summarises the validation outcome. Both the inter-
nal and experimental validation showed RMSEOLS = 0.16–0.17. This
error was a sixth of the entire 0–1 range of the Tpot scale. As Tpot
summarises three concentration levels 1% to 0.1% to 0.01% (w/v)
with a 10-fold span between each step, the accuracy was inter-
preted as to conﬁrm that the model could predict within which
10-fold concentration a given permeation enhancer was effective.
Likewise, for the literature validation the RMSE was 0.39, which
corresponds to less than half of one unit on the pEC50 scale. One
unit of pEC50 is equal to a 10-fold change in 50% effective
concentration.
Fig. 2 shows plots of the three types of validations. In part A and
B the predicted Tpot values are plotted against the measured values
for the training set data from Whitehead et al. [13,14] and for the
experimental data set. Fig. 2C depict the correlation between pre-
dicted Tpot potencies and the actual pEC50 values for the literature
test set. The internal LOO validation correlation coefﬁcient
was lower, rp2 = 0.57 (Fig. 2A), than for the external test-sets,
rp
2 = 0.65–0.66 (Figs. 2B and 1C).
Eleven permeation enhancers were evaluated in Caco-2 mono-
layers as an experimental test set (Fig. 2B). Biotin and benzoate
are widely used food additives and were intended as negative
decscriptors (265)
-fit
R, predictions
Reported TEER
Decrease
Reported molecule
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mol-files
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MOE :
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Partial charge
Minimisation
make 
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R
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R, descriptor filtering
30 descriptors
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R
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Fig. 1. Scheme of the modelling process. From top, TEER-data and provided
chemical identiﬁcation (CAS) were processed into TEER potency (Tpot) and
molecular descriptors. Descriptor ﬁltering is embedded in the leave-on-out cross-
validation (LOO-CV). The ﬁnal random forest model was both used for prediction of
external test sets and for diagnostic interpretation through the rfFC-package. R (R)
and molecular operating environment (MOE) are software applications. CCL, carbon
chain length, molecular descriptor, see Table 1.
Table 3
Permeation enhancers from literature tested in Caco-2 monolayers. EC50% is the
estimated concentration (w/V)% where the permeation enhancer will lower TEER 50%.
pEC50 is the negative logarithm to EC50%. RF predicted potency (w/V)% is the average
ability of the permeation enhancer to lower TEER at 1%. 0.1% and 0.01% (w/V)%.
CAS Compound name EC50,
(w/V)%
pEC50 Refs.
6080-33-7 Simomenine (SM) 2.0 .30 [26]
81-24-3 Tauro cholate (TC) .80 .096 [27,28]
474-25-9 Cheno deoxy cholate (CDC) .50 .30 [28]
128-13-2 Ursocholate (UC) .50 .30 [28]
29836-26-8 Glyco octyl (c8G) .40 .40 [29]
68797-35-3 Glycyrrhizinate (GC) 50 .70 [30]
325465-45-0 Myristoyl glycerol
phosphate (c14GP)
.10 1.0 [31]
20559-18-6 Lauryl glycerol phospho
choline (c12GPC)
.025 1.6 [31]
29557-51-5 Dodecyl phosphate choline
(c12PC)
.021 1.7 [31]
Table 4
Summary of the validation of the random forest QSAR model predicting potency
(%TEER) of permeation enhancers in Caco-2 monolayer. Tpot, a measure of enhancer
potency deﬁned as mean decrease of %TEER when applying 1%, 0.1% and 0.01%(w/v) in
Caco-2 monolayers. pEC50 is the estimated concentration of which %TEER is
decreased 50%. CV-LOO, internal cross validation – LOO. RMSEols, root mean square
error of ordinary least square prediction ﬁt. (a) RMSE, root-mean-square-error
adjusted to compare across Tpot and pEC50 (Eq. (3) in Section 2).
Training-set Test-set,
experimental
Test-set,
literature
Number of enhancers 41 11 9
Data origin 1 article Experimental 7 articles
Target value Tpot Tpot pEC50%(Tpota )
Model correlation, rp2 57% (LOO-CV) 66% 65%
Model error, RMSEOLS 0.17 0.16 0.39(0.16a)
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controls. None of these compounds were measured to be potent
permeation enhancers. All permeation enhancers in the experi-
mental test set, with the exception of biotin, were well predicted.
Biotin was predicted to elicit a moderate potency, but was devoid
of any signiﬁcant effects when tested in Caco-2 cells. Three
compounds SDS, C6 and PCC from the training set were retested
to verify, that the experimental setup applied here could reproduce
ﬁndings from Whitehead et al. (data not shown).
Fig. 2C show the predicted Tpot potencies and the actual pEC50
values for the literature test set. The nine enhancers were surfac-
tants with a single well deﬁned molecular structure and sufﬁcient
data points published to estimate a pEC50 value. The range of
interpolated pEC50 values from the literature data ranged from
0.3 to 1.7 corresponding to that the most potent permeation
enhancer had 100 times higher potency than the weakest.
Three of the nine compounds Myristoyl glycerol phosphate
(c14GP), Lauryl glycerol phospho choline (c12PC) and Dodecyl
phosphate choline (c12GPC) were markedly more potent than pre-
dicted by the model. The exact predicted rankings of the second
most and third most potent compounds of the experimental
test-set were not correct, but within the expected uncertainty of
the model. The same was seen for the group of low potent perme-
ation enhancers.
4.2. Reviewing descriptors useful for prediction of permeation
enhancement
Of the 266 descriptors assessed, 30 descriptors were applied
after ﬁltering in the model. Names and grouping of the used
descriptors can be seen in Table 2 in the method section. The 16
most important descriptors were included in a Spearman rank cor-
relation matrix depicting their internal rank correlation within the
training set (Fig. 3) and their rank correlation with the target
parameter Tpot. The strongest absolute correlation coefﬁcient,
0.89, was between variables PEOE_VSA-1 and logP.oW. No correla-
tion could exceed the correlation ﬁlter limit of 0.9, as described in
Section 2. All 16 descriptors were found to be rank correlated with
the target value Tpot. The descriptors absolute rank correlations to
Tpot ranged from rs = 0.34 to rs = 0.63.
To interpret the precise contribution of each descriptor within
the model, a diagnostic method termed ‘Feature Contributions’
[23,24] was used. A novel diagnostic plot of the feature contribu-
tions is presented in Fig. 4 The feature contributions of the 16 most
important descriptors describing permeation enhancer-potency
(Tpot) in the training-set were plotted against their respective
descriptor values. This provided an intuitively graphical interpreta-
tion of how features within the random forest-QSAR model context
affected the Tpot prediction. It represents an innovative way to
graphically present the computed feature contributions. This
expansion of a regular random forest model summarises the total
partial descriptor contribution for any permeation enhancer in
the training set. The predicted Tpot values for a given enhancer
are equal to the sum of all partial descriptor contributions, which
again is dependent of the actual feature values, as outlined in Fig. 4.
Fig. 4 shows that descriptor [2, BCUT_SLOGP_0], and [3,
vsurf_ID8] had sharp thresholds separating the positive (i.e., bene-
ﬁcial) and negative contributions to the Tpot value of each perme-
ation enhancer. For [1, dipole] there was also a separation
between positive and negative contribution to the Tpot value.
R2  = 0.570
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Fig. 2. Validation plots of random forest-QSAR model predicting the potency
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validating the predictability within the training-set, (B) validation of experimental
test set, (C) validation of literature test set. Tpot, mean decrease of %TEER in Caco-2
monolayers of a given permeation enhancer applied at concentrations of 1%, 0.1%
and 0.01%. pEC50, negated 10 base logarithm of concentration (%w/v) of 50% TEER.
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Fig. 3. Spearman-correlation matrix of the 16 most important molecular descrip-
tors listed by decreasing variable importance (most important ﬁrst) within the
random forest-model. The target variable Tpot, the ability of permeation enhancers
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Good permeation enhancers, compounds with high Tpot values, had
high dipole > 3, [2, BCUT_SLOGP_0] below 2.7 and [3,
vsurf_ID8] > 1.
[1, dipole] reﬂected the overall dipole moment calculated from
the partial charges of the molecule. The descriptor contribution of
[1, dipole] within the random forest model was well described as a
function of the descriptor value itself. Thus, there was no interac-
tion with other descriptors. On the contrary, the descriptor contri-
butions of descriptor [4, CCL], the maximum aliphatic carbon chain
length, varied for many permeation enhancers having the exact
same chain length. This pointed to an interaction phenomenon
between descriptors. When only emphasising permeation enhan-
cer above the threshold value for dipole > 3, these permeation
enhancers were all accredited positively for having a high CCL
value. Oppositely, enhancers with dipole < 3 were accredited
neutral for any CCL value. The interpretation drawn was that mole-
cules with a high dipole moment are likely to have a hydrophilic
domain and if combined with an aliphatic carbon chain of
length > 10, the molecules are likely to have surfactant properties.
Conversely, compounds with no signiﬁcant hydrophilic groups
such as oils, would not function as enhancers alone despite long
carbon chains.
Descriptor [3, vsurf_ID8] reﬂected the hydrophilic domains sep-
aration from the lipophilic domains which was expected to be a
central surfactant-like property. More precisely, the [3,
vsurf_ID8] reﬂected the distribution of hydrophobic or hydrated
domains and their distance from the mass centre. It was observed
that the model evaluated low [14, Vsurf_CP] values as being bene-
ﬁcial. [14, Vsurf_CP] is a micelle critical packing parameter. Cone
shaped surfactants would in generally have a low [14, Vsurf_CP]
value and thereby a low critical packing number. A low critical
packing number favours micellar aggregation, not liposomal.
Throughout Fig. 4, the descriptors were generally declining in
magnitude of feature contributions, and thus less inﬂuential.
5. Discussion
The random forest-QSAR model of permeation enhancement in
Caco-2 cells was shown to provide reasonable estimates of perme-
ation enhancer potency. Such a model has to the knowledge of the
authors not been developed previously. Within the paradigm, that
surfactant-like properties are key features of most enhancers, it
was conﬁrmed that a model could be constructed inspired by the
in silico, in vitro and in vivo models of surfactant surface tension
depression [9,11,12].
In the case of a new modelling area, a large amount of descrip-
tors could possibly become useful. However, the relatively small
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Fig. 4. Random forest feature contributions diagnostics. Scatter plots of partial descriptor contributions versus the individual descriptor values for each observation of the
training set for the 16 descriptors with highest ‘importance’ within the random forest model. Scatter plots enumerated in descending order of ‘importance’. Dashed trend lines
were added to the plots. Each plot outlines a partial function of a variable as its role in the model.
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size of training examples makes such a selection process challeng-
ing. The training set of 41 permeation enhancers and 266 descrip-
tors is an example of sparse (small n – large p) modelling which
can lead to overﬁtted non-generalisable models. Filtering/pruning
constants, redundant and non-correlated descriptors improve
model performance.
The ensemble method, random forest, is an extension of the
classiﬁcation and regression tree, CART. Decision tree models
branch out/split data into increasingly smaller sub groups of sam-
ples having the most similar target response. Such CART decision
trees are highly adaptable of many types of data, but also easily
overﬁtted to the training data. Thus, the model becomes adaptable
but highly noise sensitive. The random forest model is an extra
layer to the CART, reducing noise without losing its adeptness. In
short, random forest is an ensemble of many of such uncorrelated
decision trees (e.g., 500). Though each tree is susceptible to ran-
dom inference, the average prediction of many decision trees have
been shown to be much less prone to overﬁt thus its conclu-
sions/predictions are more generalisable across data sets [17].
That said, the conclusions from any model approach will always
be limited by the diversity of the training set. In this example, sci-
entiﬁc literature, the basis of this model training, tend to have a
bias towards not reporting any compounds which lack an enhanc-
ing effect. In the case of this training set, all compounds elicited at
least a low enhancement effect. A feature of decision tree-based
models is that, they cannot extrapolate beyond the target range
(Tpot) of the training set. Likewise, caffeine and benzoate were pre-
dicted in absolute terms to be more potent than experimentally
measured, as no learning examples could suggest such a weak
potency. Nonetheless, this is not of much practical concern in
terms of predicting new permeation enhancer candidates. A useful
model does not have to distinguish very weak enhancers from
non-enhancers.
C10, sodium decanoate, is one of the most described enhancers
in literature [7,9,32,33]. Amongst the reported mechanisms of C10
are phosphorylation cascades and intracellular calcium signalling
leading to tight junction opening [9,33]. Such mechanisms are far
too complex to be captured from a training sample of this size.
Conceivably, this may be why C10 was predicted to be a mediocre
permeation enhancer, yet elicited a relatively stronger potency
(Fig. 2B), caused by components not captured by the model. It is
expected that doubling or tripling the size of the training set would
improve prediction accuracy signiﬁcantly. This would require test-
ing another 40–80 permeation enhancers in three concentrations
in Caco-2 monolayer.
Fig. 4, the feature contributions versus descriptor values of each
training permeation enhancer, provides a novel and very useful
way to learn from the random forest-model. For example, a mole-
cule having a dipole > 3, a Vsurf_ID8 > 1 and a BCUT_SLOGP_
0 < 2.7 and CCL > 10 would appear to bear promising starting
point. Furthermore, the data in Fig. 4 suggested interaction for
e.g. CCL > 10, only contributing positively conditioned when
dipole > 3. That carbon chain length is only conditionally advanta-
geous matches the general understanding of surfactant-like prop-
erties. Such simple rules can help to understand what
modiﬁcations of an enhancer can be made without incurring a loss
of potency. The abundance of partial charge related descriptors
(see Table 2) was interpreted as a consequence of, that most sur-
factants have one or more polar domains neighbouring carbon
hydride domains and an induced dipole moment across the border
[12].
The feature contributions technique represents a novel
approach to data analysis and has the potential to be employed
as a powerful explorative tool within many scientiﬁc areas. QSAR
models based on algorithm models such as random forest are
designed to map associations (not necessarily causal) between fea-
tures and the target parameters to optimise predictions. It should
be noted that this is also the case for classical statistical approaches
[16]. Nevertheless, as discussed above, the suggestions from the
feature contributions are plausible causal from a physicochemical
point of view.
Other core aspects relating to oral protein formulation such as
solubility, stability and metabolism are not encompassed in the
existing approach. Thus, their inclusion is necessary in order to
yield a fully predictive model of protein permeation. When design-
ing/screening for new enhancers as excipients in protein-based
drug formulations, various other requirements, such as solubility,
should be considered.
Thus, by applying the described in silico model an a priori pre-
diction of the permeation enhancer potency of a surfactant can
be determined based upon its structure and hence obviate the need
for extensive permeability screening of novel compounds.
6. Conclusions
Random forest-QSAR modelling utilising molecular descriptors
calculated from the molecular structure was shown useful for pre-
dicting permeation enhancer potency. Although absorption of pro-
teins is a complex biologic phenomena, the surfactant-like
properties of permeation enhancers comprise a relatively manage-
able component.
Sparse data combined with the biological noise (unexplained)
component is a challenge to build a robust predictive model. To
reduce the estimation error, the prediction challenge was allevi-
ated in two ways:
(1) TEER readings of three concentration levels were joined into
a single value target (Tpot) to create an approachable mod-
elling question: Is the potency of a new surfactant-like
enhancer high, medium or low?
(2) Filtering of correlated descriptors to reduce redundant infor-
mation and to remove descriptors with no univariate corre-
lation to target parameter was performed to avoid too many
descriptors being progressed to the random forest model
with few training examples.
From the validations employed i.e., internal cross-validation,
experimental validation and literature validation, the model was
found to predict potency of permeation enhancers. Furthermore,
it was possible to extract common structural features for high
potency enhancers. Such knowledge is useful to assess the credibil-
ity of the built model and/or inspire our understanding of what
makes a surfactant-like permeation enhancer potent.
Hereby, we have outlined how to robustly perform in silico
screening for permeation enhancers with non-linear random for-
est, with the possibility to assess and learn from the model. The
provided QSAR model forms a good basis for a systematically
approach for the development of oral therapeutics formulated with
potent permeation enhancers.
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